The Money Runner
CNBC – GILD Beats & AMGN Misses – David from the floor of the NYSE
http://youtu.be/18LEC6M-_1U David reacts to GILD and AMGN earnings from the floor of the exchange on CNBC’s Closing Bell
Gilead’s (GILD) $1000 Pill
By David Nelson, CFA Gilead (GILD) was ground zero for the Biotech sell-off. The sector is down about 25% from its highs made earlier in the year and now (GILD) may be where the sector makes its stand. Unlike Amazon (AMZN), Netflix (NFLX), Tesla (TSLA) and others that have been hit hard by the recent […]
